CD8A and neoplasm: Because tumor cells do not efficiently present immunostimulatory epitopes to CD8+ T cells, potentially due to subpar antigen processing or surface downregulation of MHCI, antigen-presenting cells, specifically dendritic cells (DCs) capable of cross-presenting tumor-derived antigens, are often required to elicit potent CD8+ T cell immunity.